awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q43165555-1BA664AD-F40B-470B-BFB7-E5D42582704F
Q43165555-1BA664AD-F40B-470B-BFB7-E5D42582704F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43165555-1BA664AD-F40B-470B-BFB7-E5D42582704F
Ipragliflozin in combination with metformin for the treatment of Japanese patients with type 2 diabetes: ILLUMINATE, a randomized, double-blind, placebo-controlled study.
P2860
Q43165555-1BA664AD-F40B-470B-BFB7-E5D42582704F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43165555-1BA664AD-F40B-470B-BFB7-E5D42582704F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
eca25a9199642ff4dfebbaac759c3411d96bdcd4
P2860
Randomized, placebo-controlled, double-blind glycemic control trial of novel sodium-dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus